EYEPOINT PHARMACEUTICALS INC. - COMMON STOCK
5.6800
23-مايو-25 13:45:00
15 متأخرة بدقائق
الأسهم
+0.0800
+1.43%
نطاق اليوم
5.4550 - 5.7000
ISIN
N/A
المصدر
NASDAQ
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 مايو 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint Announces Participation at Upcoming Investor Conferences
13 مايو 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments
07 مايو 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025
30 أبريل 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 أبريل 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
27 مارس 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17 مارس 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
05 مارس 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint Announces Participation at Upcoming Investor Conferences
04 مارس 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025
26 فبراير 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference
25 فبراير 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17 فبراير 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
05 فبراير 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint to Present at Guggenheim SMID Cap Biotech Conference
30 يناير 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 يناير 2025 04:00:00 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >